Lung cancer
ME3 Meet the expert
Genetics, pathology and therapy of neuroendocrine tumours of the lung
Clinical
Registration for this session is additional to the congress registration fee and is €122 on site, €110 standard.
Aims : Recently, knowledge about the genetics, pathology, and therapy of neuroendocrine lung tumours has increased hugely. This session is based on the 2015 WHO classification of tumours of the lung and other recent publications and will discuss (1) the genetic findings in typical and atypical carcinoids, (2) the pathological and differential diagnoses of pulmonary neuroendocrine tumours, (3) the genetic alterations in high grade carcinomas (SCLC and LCNEC), and (4) the treatment regimens for patients with lung neuroendocrine tumours.
Target audience :
Allied health professional, Anaesthesiologist, Clinician, Epidemiologist, Fellow, General practitioner, Junior member, Nurse, Oncologist, Pathologist, Patient, Pharmaceutical industry representative, Pulmonologist, Radiologist, Researcher, Resident, Respiratory physician, Scientist, Student, Thoracic endoscopist, Thoracic surgeon
13:00
Genetics, pathology, and therapy of neuroendocrine tumours of the lung
G. Rossi(Ravenna, Italy)
COI
1
1390
. . .
